Search research articles
Contact Us
Filters
Showing results (731-740 of 784) with videos related to
Page
of 79
Sort By:
Environment International
|
November 6, 2013
Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study
Anne P Starling, Stephanie M Engel, Kristina W Whitworth, et al.
Molecular Cancer Therapeutics
|
April 7, 2016
Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation
Joo Ern Ang, Rupinder Pandher, Joo Chew Ang, et al.
American Journal of Epidemiology
|
February 22, 2014
Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study
Anne P Starling, Stephanie M Engel, David B Richardson, et al.
ESMO Open
|
January 22, 2026
Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1
C Vaklavas, M Oliveira, A C Armstrong, et al.
International Journal of Surgery (London, England)
|
June 27, 2024
Global assessment of military and civilian trauma systems integration: a scoping review
Michael D Baird, Emad S Madha, Matthew Arnaouti, et al.
Nature Communications
|
June 10, 2022
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
R C Coombes, P D Badman, J P Lozano-Kuehne, et al.
Leukemia
|
August 11, 2015
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial
J C Strefford, L Kadalayil, J Forster, et al.
Nature Communications
|
March 6, 2025
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
R C Coombes, Sacha Howell, Simon R Lord, et al.
The Journal of Surgical Research
|
December 1, 2022
Military and Civilian Trauma System Integration: A Global Case Series
Ghassan T Alswaiti, Tamara J Worlton, Matthew Arnaouti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial
Iseult M Browne, Javier Pascual, Rosalind J Cutts, et al.
Page
of 79
Search research articles
Search
Showing results (731-740 of 784) with videos related to
Sort By:
Page
of 79
Environment International
|
November 6, 2013
Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study
Anne P Starling, Stephanie M Engel, Kristina W Whitworth, et al.
Molecular Cancer Therapeutics
|
April 7, 2016
Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation
Joo Ern Ang, Rupinder Pandher, Joo Chew Ang, et al.
American Journal of Epidemiology
|
February 22, 2014
Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study
Anne P Starling, Stephanie M Engel, David B Richardson, et al.
ESMO Open
|
January 22, 2026
Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1
C Vaklavas, M Oliveira, A C Armstrong, et al.
International Journal of Surgery (London, England)
|
June 27, 2024
Global assessment of military and civilian trauma systems integration: a scoping review
Michael D Baird, Emad S Madha, Matthew Arnaouti, et al.
Nature Communications
|
June 10, 2022
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
R C Coombes, P D Badman, J P Lozano-Kuehne, et al.
Leukemia
|
August 11, 2015
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial
J C Strefford, L Kadalayil, J Forster, et al.
Nature Communications
|
March 6, 2025
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
R C Coombes, Sacha Howell, Simon R Lord, et al.
The Journal of Surgical Research
|
December 1, 2022
Military and Civilian Trauma System Integration: A Global Case Series
Ghassan T Alswaiti, Tamara J Worlton, Matthew Arnaouti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial
Iseult M Browne, Javier Pascual, Rosalind J Cutts, et al.
Page
of 79